136 related articles for article (PubMed ID: 23277284)
1. EIF4E over-expresses and enhances cell proliferation and cell cycle progression in nasopharyngeal carcinoma.
Wu M; Liu Y; Di X; Kang H; Zeng H; Zhao Y; Cai K; Pang T; Wang S; Yao Y; Hu X
Med Oncol; 2013 Mar; 30(1):400. PubMed ID: 23277284
[TBL] [Abstract][Full Text] [Related]
2. LMP1 stimulates the transcription of eIF4E to promote the proliferation, migration and invasion of human nasopharyngeal carcinoma.
Zhao Y; Pang TY; Wang Y; Wang S; Kang HX; Ding WB; Yong WW; Bie YH; Cheng XG; Zeng C; Yao YH; Li Q; Hu XR
FEBS J; 2014 Jul; 281(13):3004-18. PubMed ID: 24814906
[TBL] [Abstract][Full Text] [Related]
3. [Over-expressions of p-eIF4E and p-4EBP1 are associated with poor prognosis in nasopharyngeal carcinoma].
Zheng J; Zhang C; Zhang Y; Pei J; Fan S
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Apr; 33(4):531-535. PubMed ID: 28395726
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylated Mnk1 and eIF4E are associated with lymph node metastasis and poor prognosis of nasopharyngeal carcinoma.
Zheng J; Li J; Xu L; Xie G; Wen Q; Luo J; Li D; Huang D; Fan S
PLoS One; 2014; 9(2):e89220. PubMed ID: 24551240
[TBL] [Abstract][Full Text] [Related]
5. Positive Correlative over-Expression between eIF4E and Snail in Nasopharyngeal Carcinoma Promotes its Metastasis and Resistance to Cisplatin.
Yao Y; Pang T; Cheng Y; Yong W; Kang H; Zhao Y; Wang S; Hu X
Pathol Oncol Res; 2020 Jul; 26(3):1639-1649. PubMed ID: 31512056
[TBL] [Abstract][Full Text] [Related]
6. Over-expression of BCAT1, a c-Myc target gene, induces cell proliferation, migration and invasion in nasopharyngeal carcinoma.
Zhou W; Feng X; Ren C; Jiang X; Liu W; Huang W; Liu Z; Li Z; Zeng L; Wang L; Zhu B; Shi J; Liu J; Zhang C; Liu Y; Yao K
Mol Cancer; 2013 Jun; 12():53. PubMed ID: 23758864
[TBL] [Abstract][Full Text] [Related]
7. Suppression of oncogenic protein translation via targeting eukaryotic translation initiation factor 4E overcomes chemo-resistance in nasopharyngeal carcinoma.
Xu M; Tao Z; Wang S; Jiang Y; Qu M
Biochem Biophys Res Commun; 2019 May; 512(4):902-907. PubMed ID: 30929914
[TBL] [Abstract][Full Text] [Related]
8. Over-expression of eukaryotic translation initiation factor 4 gamma 1 correlates with tumor progression and poor prognosis in nasopharyngeal carcinoma.
Tu L; Liu Z; He X; He Y; Yang H; Jiang Q; Xie S; Xiao G; Li X; Yao K; Fang W
Mol Cancer; 2010 Apr; 9():78. PubMed ID: 20398343
[TBL] [Abstract][Full Text] [Related]
9. Inflammatory CXCL12-CXCR4/CXCR7 axis mediates G-protein signaling pathway to influence the invasion and migration of nasopharyngeal carcinoma cells.
Qiao N; Wang L; Wang T; Li H
Tumour Biol; 2016 Jun; 37(6):8169-79. PubMed ID: 26715277
[TBL] [Abstract][Full Text] [Related]
10. Zinc-finger protein YY1 suppresses tumor growth of human nasopharyngeal carcinoma by inactivating c-Myc-mediated
Li M; Liu Y; Wei Y; Wu C; Meng H; Niu W; Zhou Y; Wang H; Wen Q; Fan S; Li Z; Li X; Zhou J; Cao K; Xiong W; Zeng Z; Li X; Qiu Y; Li G; Zhou M
J Biol Chem; 2019 Apr; 294(15):6172-6187. PubMed ID: 30718276
[TBL] [Abstract][Full Text] [Related]
11. ShRNA-mediated silencing of the ubiquitin-specific protease 22 gene restrained cell progression and affected the Akt pathway in nasopharyngeal carcinoma.
Zhuang YJ; Liao ZW; Yu HW; Song XL; Liu Y; Shi XY; Lin XD; Zhou TC
Cancer Biol Ther; 2015; 16(1):88-96. PubMed ID: 25482932
[TBL] [Abstract][Full Text] [Related]
12. Repurposing the FDA-Approved Antiviral Drug Ribavirin as Targeted Therapy for Nasopharyngeal Carcinoma.
Huq S; Casaos J; Serra R; Peters M; Xia Y; Ding AS; Ehresman J; Kedda JN; Morales M; Gorelick NL; Zhao T; Ishida W; Perdomo-Pantoja A; Cecia A; Ji C; Suk I; Sidransky D; Brait M; Brem H; Skuli N; Tyler B
Mol Cancer Ther; 2020 Sep; 19(9):1797-1808. PubMed ID: 32606016
[TBL] [Abstract][Full Text] [Related]
13. 4EGI-1 induces apoptosis and enhances radiotherapy sensitivity in nasopharyngeal carcinoma cells via DR5 induction on 4E-BP1 dephosphorylation.
Wang W; Li J; Wen Q; Luo J; Chu S; Chen L; Qing Z; Xie G; Xu L; Alnemah MM; Li M; Fan S; Zhang H
Oncotarget; 2016 Apr; 7(16):21728-41. PubMed ID: 26942880
[TBL] [Abstract][Full Text] [Related]
14. LINC01116 accelerates nasopharyngeal carcinoma progression based on its enhancement on MYC transcription activity.
Xing H; Sun H; Du W
Cancer Med; 2020 Jan; 9(1):269-277. PubMed ID: 31703161
[TBL] [Abstract][Full Text] [Related]
15. eIF4E activation is commonly elevated in advanced human prostate cancers and significantly related to reduced patient survival.
Graff JR; Konicek BW; Lynch RL; Dumstorf CA; Dowless MS; McNulty AM; Parsons SH; Brail LH; Colligan BM; Koop JW; Hurst BM; Deddens JA; Neubauer BL; Stancato LF; Carter HW; Douglass LE; Carter JH
Cancer Res; 2009 May; 69(9):3866-73. PubMed ID: 19383915
[TBL] [Abstract][Full Text] [Related]
16. Ribavirin sensitizes nasopharyngeal carcinoma to 5-fluorouracil through suppressing 5-fluorouracil-induced ERK-dependent-eIF4E activation.
Hu Z; Zhen L; Li Q; Han Q; Hua Q
Biochem Biophys Res Commun; 2019 Jun; 513(4):862-868. PubMed ID: 31000196
[TBL] [Abstract][Full Text] [Related]
17. Control of the MYC-eIF4E axis plus mTOR inhibitor treatment in small cell lung cancer.
Matsumoto M; Seike M; Noro R; Soeno C; Sugano T; Takeuchi S; Miyanaga A; Kitamura K; Kubota K; Gemma A
BMC Cancer; 2015 Apr; 15():241. PubMed ID: 25884680
[TBL] [Abstract][Full Text] [Related]
18. FLJ10540 is associated with tumor progression in nasopharyngeal carcinomas and contributes to nasopharyngeal cell proliferation, and metastasis via osteopontin/CD44 pathway.
Chen CH; Shiu LY; Su LJ; Huang CY; Huang SC; Huang CC; Yin YF; Wang WS; Tsai HT; Fang FM; Chuang WC; Kang HC; Hwang CF
J Transl Med; 2012 May; 10():93. PubMed ID: 22591637
[TBL] [Abstract][Full Text] [Related]
19. Flotillin-2 promotes cell proliferation via activating the c-Myc/BCAT1 axis by suppressing miR-33b-5p in nasopharyngeal carcinoma.
Liu R; Liu J; Wu P; Yi H; Zhang B; Huang W
Aging (Albany NY); 2021 Mar; 13(6):8078-8094. PubMed ID: 33744853
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA let-7 suppresses nasopharyngeal carcinoma cells proliferation through downregulating c-Myc expression.
Wong TS; Man OY; Tsang CM; Tsao SW; Tsang RK; Chan JY; Ho WK; Wei WI; To VS
J Cancer Res Clin Oncol; 2011 Mar; 137(3):415-22. PubMed ID: 20440510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
